BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rauf A, Patel S, Imran M, Maalik A, Arshad MU, Saeed F, Mabkhot YN, Al-showiman SS, Ahmad N, Elsharkawy E. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018;107:555-62. [DOI: 10.1016/j.biopha.2018.08.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Guan S, Li H, Li D, Liu D, Wang J, Zhu W, Xing G, Yue L, Cai D, Zhang Q. Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis. Drug Deliv 2023;30:2181746. [PMID: 36803115 DOI: 10.1080/10717544.2023.2181746] [Reference Citation Analysis]
2 Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K. Heat shock proteins and cancer: The FoxM1 connection. Biochem Pharmacol 2023;211:115505. [PMID: 36931349 DOI: 10.1016/j.bcp.2023.115505] [Reference Citation Analysis]
3 Liu A, Xun S, Zhou G, Zhang Y, Lin L. Honokiol alleviates sepsis-associated cardiac dysfunction via attenuating inflammation, apoptosis and oxidative stress. J Pharm Pharmacol 2023;75:397-406. [PMID: 36718013 DOI: 10.1093/jpp/rgac102] [Reference Citation Analysis]
4 Gahtori R, Tripathi AH, Kumari A, Negi N, Paliwal A, Tripathi P, Joshi P, Rai RC, Upadhyay SK. Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms. Futur J Pharm Sci 2023;9:14. [DOI: 10.1186/s43094-023-00465-5] [Reference Citation Analysis]
5 Wang X, Shao G, Hong X, Shi Y, Zheng Y, Yu Y, Fu C. Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway. Pharmaceuticals (Basel) 2023;16. [PMID: 36678567 DOI: 10.3390/ph16010070] [Reference Citation Analysis]
6 Balasubramaniam A, Li G, Ramanathan A, Mwangi SM, Hart CM, Arbiser JL, Srinivasan S. SIRT3 activation promotes enteric neurons survival and differentiation. Sci Rep 2022;12:22076. [PMID: 36543902 DOI: 10.1038/s41598-022-26634-9] [Reference Citation Analysis]
7 Hermawan A, Putri H, Hanif N, Fatimah N, Prasetio HH. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen. Front Oncol 2022;12:1019025. [PMID: 36601474 DOI: 10.3389/fonc.2022.1019025] [Reference Citation Analysis]
8 Hong SH, Park C, Hwangbo H, Bang E, Kim SO, Shim J, Park S, Lee H, Leem S, Kim G, Choi YH. Activation of Heme Oxygenase-1 is Involved in the Preventive Effect of Honokiol against Oxidative Damage in Human Retinal Pigment Epithelial Cells. Biotechnol Bioproc E 2022. [DOI: 10.1007/s12257-022-0174-x] [Reference Citation Analysis]
9 Li H, Li W, Li J, Li S, Kuang L, Pang F, Jiang H, Jin H, Bian X. Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway. Cells 2022;11. [PMID: 36428991 DOI: 10.3390/cells11223562] [Reference Citation Analysis]
10 Liu X, Gao L, Huang X, Deng R, Wei X, Lu J, Li S. Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease. Front Pharmacol 2022;13:1019629. [DOI: 10.3389/fphar.2022.1019629] [Reference Citation Analysis]
11 Wang X, Liu Q, Fu Y, Ding R, Qi X, Zhou X, Sun Z, Bao J. Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight. Molecules 2022;27:6441. [DOI: 10.3390/molecules27196441] [Reference Citation Analysis]
12 Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01650-5] [Reference Citation Analysis]
13 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
14 Guo T, Zheng B, He H, Chen L. Effects of non-covalent binding of lignans with rice starch driven by high-pressure homogenization on the starch structure and in vitro nutritional characteristics. Food Funct 2022. [PMID: 36000543 DOI: 10.1039/d2fo00798c] [Reference Citation Analysis]
15 He X, Wei Y, Wang S, Zhang J, Gao Y, Qian S, Pang Z, Heng W. Improved Pharmaceutical Properties of Honokiol via Salification with Meglumine: an Exception to Oft-quoted ∆pKa Rule. Pharm Res 2022. [PMID: 35836038 DOI: 10.1007/s11095-022-03335-6] [Reference Citation Analysis]
16 Wang Y, Wu P, Liu F, Chen J, Xue J, Qin Y, Chen F, Wang S, Ji L. Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents. Eur J Med Chem 2022;240:114593. [PMID: 35820350 DOI: 10.1016/j.ejmech.2022.114593] [Reference Citation Analysis]
17 Khan M, Shamim S. Anisi Stellati Fructus, a Significant Traditional Chinese Medicine (TCM) Herb and Its Bioactivity against Gastric Cancer. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/4071489] [Reference Citation Analysis]
18 Yu M, Aoki D, Akita T, Fujiyasu S, Takada S, Matsushita Y, Yoshida M, Fukushima K. Distribution of lignans and lignan mono/diglucosides within Ginkgo biloba L. stem. Phytochemistry 2022;196:113102. [DOI: 10.1016/j.phytochem.2022.113102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yi X, Qi M, Huang M, Zhou S, Xiong J. Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth. Front Pharmacol 2022;13:796763. [PMID: 35350760 DOI: 10.3389/fphar.2022.796763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Hazafa A, Iqbal MO, Javaid U, Tareen MBK, Amna D, Ramzan A, Piracha S, Naeem M. Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review. Clin Transl Oncol 2022;24:432-45. [PMID: 34609675 DOI: 10.1007/s12094-021-02709-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
21 he A, Yu H, Hu Y, Chen H, Li X, Shen J, Zhuang R, Chen Y, Richard SB, Luo M, Lv D. Honokiol improves endothelial function in type 2 diabetic rats via alleviating oxidative stress and insulin resistance. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.02.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zeng J, Bao T, Yang K, Zhu X, Wang S, Xiang W, Ge A, Zeng L, Ge J. The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review. Front Immunol 2022;13:1047550. [PMID: 36818470 DOI: 10.3389/fimmu.2022.1047550] [Reference Citation Analysis]
23 Álvarez-caballero JM, Coy-barrera E. Lignans. Antioxidants Effects in Health 2022. [DOI: 10.1016/b978-0-12-819096-8.00050-1] [Reference Citation Analysis]
24 Pérez Ortiz M, Guerrero-castilla A, Quispe Chávez EC. Nanophytotherapeutics for Cancer. Innovative Approaches for Nanobiotechnology in Healthcare Systems 2022. [DOI: 10.4018/978-1-7998-8251-0.ch004] [Reference Citation Analysis]
25 Chen W, Wu J, Zhan S, Lu X. Honokiol inhibits endoplasmic reticulum stress-associated lipopolysaccharide-induced inflammation and apoptosis in bovine endometrial epithelial cells. Exp Ther Med 2021;22:1476. [PMID: 34765017 DOI: 10.3892/etm.2021.10911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cheng B, Zhu G, Meng L, Wu G, Chen Q, Ma S. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance. Eur J Med Chem 2021;:113930. [PMID: 34794817 DOI: 10.1016/j.ejmech.2021.113930] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Nie W, Ding L, Lei T, Liu Z, Li J, Song L, Wu X. Biphenyl-type neolignans with NO inhibitory activity from the fruits of Magnolia tripetala. Phytochemistry Letters 2021;44:222-6. [DOI: 10.1016/j.phytol.2021.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Rauf A, Olatunde A, Imran M, Alhumaydhi FA, Aljohani ASM, Khan SA, Uddin MS, Mitra S, Emran TB, Khayrullin M, Rebezov M, Kamal MA, Shariati MA. Honokiol: A review of its pharmacological potential and therapeutic insights. Phytomedicine 2021;90:153647. [PMID: 34362632 DOI: 10.1016/j.phymed.2021.153647] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
29 Wang T, Wang H, Yang F, Gao K, Luo S, Bai L, Ma K, Liu M, Wu S, Wang H, Chen Z, Xiao Q. Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+ -activated Cl- channels. Br J Pharmacol 2021. [PMID: 34192810 DOI: 10.1111/bph.15606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Jöhrer K, Ҫiҫek SS. Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers (Basel) 2021;13:2678. [PMID: 34072312 DOI: 10.3390/cancers13112678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Mottaghi S, Abbaszadeh H. Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review. Nutr Cancer 2021;:1-18. [PMID: 34047218 DOI: 10.1080/01635581.2021.1931364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
32 Mottaghi S, Abbaszadeh H. A comprehensive mechanistic insight into the dietary and estrogenic lignans, arctigenin and sesamin as potential anticarcinogenic and anticancer agents. Current status, challenges, and future perspectives. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 33905270 DOI: 10.1080/10408398.2021.1913568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lin Y, Li Y, Zeng Y, Tian B, Qu X, Yuan Q, Song Y. Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update. Front Pharmacol 2021;12:632767. [PMID: 33815113 DOI: 10.3389/fphar.2021.632767] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
34 Pospíšil J, Konrádová D, Strnad M. Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols. Prog Chem Org Nat Prod 2021;115:115-76. [PMID: 33797642 DOI: 10.1007/978-3-030-64853-4_3] [Reference Citation Analysis]
35 Huang M, Myers CR, Wang Y, You M. Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents. Cancer Prev Res (Phila) 2021;14:285-306. [PMID: 33303695 DOI: 10.1158/1940-6207.CAPR-20-0425] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
36 Liu T, Liu H, Wang P, Hu Y, Yang R, Liu F, Kim HG, Dong Z, Liu K. Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo. Front Cell Dev Biol 2020;8:603472. [PMID: 33330500 DOI: 10.3389/fcell.2020.603472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Jin X, Yang Q, Cai N, Zhang Z. A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment. Nanomedicine (Lond) 2020;15:41-54. [PMID: 31868113 DOI: 10.2217/nnm-2018-0479] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
38 Moser BA, Escalante-Buendia Y, Steinhardt RC, Rosenberger MG, Cassaidy BJ, Naorem N, Chon AC, Nguyen MH, Tran NT, Esser-Kahn AP. Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants. Front Immunol 2020;11:511513. [PMID: 33072085 DOI: 10.3389/fimmu.2020.511513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
39 Chu C, Li J, Wang S, Weng L, Jiang L, Zhang H, Liu C, Yan J. A Simple and Sensitive Dispersive Micro-Solid-Phase Extraction Coupled with High-Performance Liquid Chromatography for Quantification of Honokiol and Magnolol in Complex Matrices. Journal of AOAC INTERNATIONAL 2020;103:1406-1411. [DOI: 10.1093/jaoacint/qsaa049] [Reference Citation Analysis]
40 Zhu S, Chen P, Chen Y, Li M, Chen C, Lu H. 3D-Printed Extracellular Matrix/Polyethylene Glycol Diacrylate Hydrogel Incorporating the Anti-inflammatory Phytomolecule Honokiol for Regeneration of Osteochondral Defects. Am J Sports Med 2020;48:2808-18. [PMID: 32762553 DOI: 10.1177/0363546520941842] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
41 Li Q, Ma Y, Liu XL, Mu L, He BC, Wu K, Sun WJ. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway. Oncol Rep 2020;44:2093-107. [PMID: 32901874 DOI: 10.3892/or.2020.7745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Xia L, Kang D, Wan D, Chu C, Chen M, Zhang S, Li X, He L, Yan J, Liu T, Peng Y. Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo. ACS Omega 2020;5:19844-52. [PMID: 32803080 DOI: 10.1021/acsomega.0c02832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Alavi M, Varma RS. Overview of novel strategies for the delivery of anthracyclines to cancer cells by liposomal and polymeric nanoformulations. Int J Biol Macromol 2020;164:2197-203. [PMID: 32763404 DOI: 10.1016/j.ijbiomac.2020.07.274] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
44 Tedasen A, Dokduang S, Sukpondma Y, Lailerd N, Madla S, Sriwiriyajan S, Rattanaburee T, Tipmanee V, Graidist P. (-)-Kusunokinin inhibits breast cancer in N-nitrosomethylurea-induced mammary tumor rats. Eur J Pharmacol 2020;882:173311. [PMID: 32619673 DOI: 10.1016/j.ejphar.2020.173311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
45 Lu X, Lu X, Zhang Z, Lv H. Preparation and Characterization of Honokiol Nanosuspensions and Preliminary Evaluation of Anti-Inflammatory Effect. AAPS PharmSciTech 2020;21:62. [PMID: 31925586 DOI: 10.1208/s12249-019-1602-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
46 Kullberg M, Francian A, Arabi A, Olsson T, Mann K, Martinson HA. Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer. Pharm Front 2019;1:e190007. [PMID: 31886474 DOI: 10.20900/pf20190007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
48 Lorente-cebrián S, Herrera K, I. Milagro F, Sánchez J, de la Garza AL, Castro H. miRNAs and Novel Food Compounds Related to the Browning Process. IJMS 2019;20:5998. [DOI: 10.3390/ijms20235998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, Chong PP, Looi CY. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells 2019;8:E1118. [PMID: 31547193 DOI: 10.3390/cells8101118] [Cited by in Crossref: 361] [Cited by in F6Publishing: 392] [Article Influence: 90.3] [Reference Citation Analysis]
50 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 23.3] [Reference Citation Analysis]
51 Wang YX, Zhu N, Zhang CJ, Wang YK, Wu HT, Li Q, Du K, Liao DF, Qin L. Friend or foe: Multiple roles of adipose tissue in cancer formation and progression. J Cell Physiol 2019;234:21436-49. [PMID: 31054175 DOI: 10.1002/jcp.28776] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
52 Colin M, Delporte C, Janky R, Lechon AS, Renard G, Van Antwerpen P, Maltese WA, Mathieu V. Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide. Cancers (Basel) 2019;11:E411. [PMID: 30909495 DOI: 10.3390/cancers11030411] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
53 Hsiao CH, Yao CJ, Lai GM, Lee LM, Whang-Peng J, Shih PH. Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells. Exp Ther Med 2019;17:4213-22. [PMID: 30988795 DOI: 10.3892/etm.2019.7419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]